WCLC 2025 - Posters & ePosters-P2.06.90 The Role of ctDNA Tumor Fraction in Advanced NSCLC and Its Impact on Patient Treatment Outcomes: A Prospective Real-World Study

P2.06.90 The Role of ctDNA Tumor Fraction in Advanced NSCLC and Its Impact on Patient Treatment Outcomes: A Prospective Real-World Study

Asset Subtitle

Aya El Helali

Meta Tag

Speaker Aya El Helali

Topic Pathology and Biomarkers